Caring to make a difference

• Recent News

  • February 2010
    

    Genscreen announces that the in-house RESET project has completed initial testing and shall be renamed “Hervian”

  • January 2010
    

    Ian Dixon, CEO of Genscreen Pty Ltd, announces that Genscreen is presently having TR400 drugs sythesised by a contractor. It is anticipated that screening results will be ready for review by March 2010

  • December 2009
    

    Genscreen announces the interim results of its preclinical development projects

  • August 2009
    

    Genscreen commences work with Qubist Molecular Design (www.qubistmd.com)

  • May 2009
    

    Genscreen Pty Ltd announces that it has reduced its operations to concentrate on core activities

• News Archives

  • January 2010
  • December 2009
  • August 2009
  • May 2009
  • February 2007
  • October 2005
  • September 2005
  • May 2005
  • April 2005
  • December 2004

• Admin Area

  • Log in
  • XHTML

• Search It!

• Useful Links

  • Web Design